Sustainable weight loss isnt just about the number on the scale
Seen in a longer historical context, the excitementand the discomfortaround menopause, hormones, and weight-loss pharmacotherapy makes sense
Serial samples beyond the 32-week endpoint were not collected, so longer-term trajectories could not be assessed
Such complications could turn deadly
Perez adds to this, also saying that over-the-counter drugs marketed as GLP-1 patches do not contain semeglutide or tirzepatide, the active ingredients in the FDA-approved prescription GLP-1 medications
These central effects translate into substantial weight loss - typically 5%-15% of body weight with current GLP-1 RAs - which directly ameliorates hepatic steatosis by reducing adipose tissue mass, reducing hepatic free fatty acid influx, and improving insulin sensitivity